UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Silo Pharma Inc (SILO)

Silo Pharma Inc (SILO)
1.1000 x 30 1.1900 x 8
Post-market by (Cboe BZX)
1.1600 +0.0300 (+2.65%) 04/23/25 [NASDAQ]
1.1000 x 30 1.1900 x 8
Post-market 1.1900 +0.0300 (+2.59%) 17:36 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.1000
Day High
1.1900
Open 1.1000
Previous Close 1.1300 1.1300
Volume 21,070 21,070
Avg Vol 93,104 93,104
Stochastic %K 65.72% 65.72%
Weighted Alpha -62.63 -62.63
5-Day Change +0.1100 (+10.48%) +0.1100 (+10.48%)
52-Week Range 0.7700 - 4.5000 0.7700 - 4.5000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,045
  • Shares Outstanding, K 4,484
  • Annual Sales, $ 70 K
  • Annual Income, $ -4,390 K
  • EBIT $ -5 M
  • EBITDA $ -5 M
  • 60-Month Beta 0.20
  • Price/Sales 66.02
  • Price/Cash Flow N/A
  • Price/Book 0.94

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9500 +22.12%
on 04/09/25
Period Open: 1.3900
1.3912 -16.61%
on 03/26/25
-0.2299 (-16.54%)
since 03/21/25
3-Month
0.9500 +22.12%
on 04/09/25
Period Open: 1.9600
2.0900 -44.49%
on 01/24/25
-0.7999 (-40.81%)
since 01/23/25
52-Week
0.7700 +50.66%
on 11/25/24
Period Open: 1.7800
4.5000 -74.22%
on 07/18/24
-0.6199 (-34.83%)
since 04/23/24

Most Recent Stories

More News
After a Patent Win, Analysts Think This Penny Stock Can Gain 465% in 2025

Amid the dynamic biopharma landscape, this penny stock is turning heads with a game-changing patent win, and analysts are buzzing with bullish projections for its potential.

SILO : 1.1601 (+3.12%)
Silo Pharma Announces Key Preclinical Study for SP-26, a Novel Non-Opioid Pain Therapeutic

Silo Pharma initiates a pharmacokinetic study for SP-26, a non-opioid treatment for chronic pain and fibromyalgia.Quiver AI SummarySilo Pharma, Inc. has announced the start of a pharmacokinetic and tolerability...

SILO : 1.1601 (+3.12%)
Silo Pharma Collaborates with Kymanox for Development of Subcutaneous Insertion Device for SP-26 Ketamine Implant

Silo Pharma collaborates with Kymanox to develop a subcutaneous device for its ketamine implant targeting chronic pain.Quiver AI SummarySilo Pharma, Inc. has announced a collaboration with Kymanox to develop...

SILO : 1.1601 (+3.12%)
Silo Pharma, Inc. Announces Promising Preclinical Results for Dual-action Treatment SPC-15 Targeting PTSD and Severe Stress-related Conditions

Silo Pharma's SPC-15 shows promising dual-target efficacy in preclinical studies for treating severe stress-related psychiatric conditions.Quiver AI SummarySilo Pharma, Inc. announced promising results...

SILO : 1.1601 (+3.12%)
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027

Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons,...

TRVN : 1.1600 (-8.66%)
IMRN : 1.7178 (-0.71%)
IMC.AX : 0.062 (-3.13%)
LLY : 829.42 (+0.23%)
ACOR : 0.6610 (-24.86%)
SILO : 1.1601 (+3.12%)
Global Alzheimer's Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027

/PRNewswire/ -- Alzheimer's disease (AD) is a progressive and neurodegenerative disorder that attacks the brain's nerve cells or neurons, which results in loss...

TRVN : 1.1600 (-8.66%)
IMRN : 1.7178 (-0.71%)
LLY : 829.42 (+0.23%)
ACOR : 0.6610 (-24.86%)
SILO : 1.1601 (+3.12%)
Silo Pharma’s SPC-15 Awarded U.S. Patent to Protect Ongoing R&D of Therapeutic for Stress-Induced Affective Disorder and Alzheimer’s Disease

ENGLEWOOD CLIFFS, NJ – May 9,  2023 – Silo Pharma, Inc.  (NASDAQ: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic...

SILO : 1.1601 (+3.12%)
Silo Pharma Commences Formulation for SPC-15 Targeting Anxiety and PTSD Stress-Related Disorders

ENGLEWOOD CLIFFS, NJ – April 19, 2023 – Silo Pharma, Inc.  (NASDAQ:SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic...

SILO : 1.1601 (+3.12%)
Silo Pharma (NASDAQ: SILO) Provides Update on Study of Ketamine Formulations for Fibromyalgia

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused around merging traditional therapeutics with psychedelic research, recently announced that it had achieved a positive...

SILO : 1.1601 (+3.12%)
Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Fibromyalgia

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has filed a provisional patent...

SILO : 1.1601 (+3.12%)

Business Summary

Silo Pharma. Inc. is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer's, and other rare neurological disorders. Silo Pharma. Inc. is based in ENGLEWOOD CLIFFS, NJ.

See More

Key Turning Points

3rd Resistance Point 1.2901
2nd Resistance Point 1.2400
1st Resistance Point 1.2001
Last Price 1.1601
1st Support Level 1.1101
2nd Support Level 1.0600
3rd Support Level 1.0201

See More

52-Week High 4.5000
Fibonacci 61.8% 3.0751
Fibonacci 50% 2.6350
Fibonacci 38.2% 2.1949
Last Price 1.1601
52-Week Low 0.7700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective